These discrepancies might be due to the difference in muscles studied or overexpression of a DNM2 mutant linked to the severe form of the disease in a developing muscle (Gibbs et al., 2014) versus endogenous expression of a DNM2 mutant linked to a milder form of AD-CNM in an adult muscle (the present study). This evidence concerns the gene DNM2 and Alzheimer disease.